We are live on ! Find out more
FLI

Family Legacy Inc Portfolio holdings

AUM $375M
1-Year Est. Return 35.98%
This Fund
S&P 500
This Quarter Est. Return
-2.2%
1 Year Est. Return
+35.98%
3 Year Est. Return
+87.75%
5 Year Est. Return
+104.83%
10 Year Est. Return
AUM
$295M
AUM Growth
-$5.62M
Cap. Flow
+$3.34M
Cap. Flow %
1.13%
Top 10 Hldgs %
23.6%
Holding
125
New
3
Increased
82
Reduced
28
Closed
4

Top Sells

Rank Stock Value
1
NVS icon
Novartis
NVS
+$374K
2
RTO icon
Rentokil
RTO
+$356K
3
GSK icon
GSK
GSK
+$262K
4
ILCG icon
iShares Morningstar Growth ETF
ILCG
+$219K
5
CAT icon
Caterpillar
CAT
+$190K

Sector Composition

Rank Sector Weight
1 Technology 13.89%
2 Industrials 13.23%
3 Healthcare 12.21%
4 Financials 12.19%
5 Consumer Staples 8.89%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ANGL icon
26
VanEck Fallen Angel High Yield Bond ETF
ANGL
$3.1B
$4.27M 1.45%
148,724
+7,862
+6% +$228K
DGRO icon
27
iShares Core Dividend Growth ETF
DGRO
$43.7B
$4.25M 1.44%
69,276
-423
-0.6% -$26.7K
UNH icon
28
UnitedHealth
UNH
$371B
$4.17M 1.41%
7,946
+121
+2% +$68.8K
BIV icon
29
Vanguard Intermediate-Term Bond ETF
BIV
$28.8B
$4.06M 1.38%
54,556
+2,041
+4% +$155K
SPDW icon
30
State Street SPDR Portfolio Developed World ex-US ETF
SPDW
$41.4B
$3.97M 1.34%
115,135
+744
+0.7% +$26.6K
LMT icon
31
Lockheed Martin
LMT
$139B
$3.96M 1.34%
8,445
+128
+2% +$69.8K
MRK icon
32
Merck
MRK
$323B
$3.48M 1.18%
34,827
+395
+1% +$40.7K
AMGN icon
33
Amgen
AMGN
$226B
$3.43M 1.16%
12,963
+134
+1% +$39.8K
DE icon
34
Deere & Co
DE
$164B
$3.41M 1.15%
8,311
+169
+2% +$71.2K
VNQ icon
35
Vanguard Real Estate ETF
VNQ
$38.6B
$3.23M 1.1%
36,881
+315
+0.9% +$29.8K
IMCG icon
36
iShares Morningstar Mid-Cap Growth ETF
IMCG
$4.11B
$3.16M 1.07%
41,304
-553
-1% -$42.3K
WM icon
37
Waste Management
WM
$90.6B
$3.02M 1.02%
14,621
+338
+2% +$72.6K
SO icon
38
Southern Company
SO
$105B
$3.02M 1.02%
36,338
-50
-0.1% -$4.39K
TDG icon
39
TransDigm Group
TDG
$67.6B
$2.89M 0.98%
2,253
+99
+5% +$130K
SBUX icon
40
Starbucks
SBUX
$119B
$2.86M 0.97%
30,870
+316
+1% +$30.6K
SOXX icon
41
iShares Semiconductor ETF
SOXX
$44.8B
$2.83M 0.96%
12,650
+393
+3% +$87.7K
NOC icon
42
Northrop Grumman
NOC
$82.1B
$2.8M 0.95%
6,067
+120
+2% +$60.4K
BAC icon
43
Bank of America
BAC
$447B
$2.74M 0.93%
59,238
+401
+0.7% +$17.6K
ELV icon
44
Elevance Health
ELV
$86.2B
$2.62M 0.89%
6,831
+232
+4% +$97.1K
GE icon
45
GE Aerospace
GE
$380B
$2.42M 0.82%
14,010
+500
+4% +$89.2K
GD icon
46
General Dynamics
GD
$107B
$2.38M 0.8%
9,085
+87
+1% +$25K
PEP icon
47
PepsiCo
PEP
$188B
$2.28M 0.77%
15,526
+190
+1% +$31.1K
DFIV icon
48
Dimensional International Value ETF
DFIV
$21.6B
$2.26M 0.76%
62,979
+7,299
+13% +$268K
BA icon
49
Boeing
BA
$184B
$2.23M 0.76%
12,988
+523
+4% +$82.1K
BRK.B icon
50
Berkshire Hathaway Class B
BRK.B
$1.14T
$2.22M 0.75%
4,909
+144
+3% +$66.5K

Similar funds

Family Legacy Inc's Q4 2024 Portfolio in Review

As of Q4 2024, Family Legacy Inc held 125 positions worth $295M, down 1.9% from $301M the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Family Legacy Inc's Q4 2024 filing shows 3 new, 82 increased, 28 reduced and 4 closed positions. Its largest new stake was Rollins: 7,200 shares worth $334K. The largest sale was Novartis, an estimated $374K.

By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 13% a quarter earlier, followed by Industrials and Healthcare.

  • Family Legacy Inc's largest Q4 2024 buy was Rollins: 7,200 shares worth $334K.
  • Family Legacy Inc added most to Dimensional International Value ETF in Q4 2024, an estimated $268K increase.
  • Family Legacy Inc's biggest Q4 2024 reduction was Caterpillar, cutting an estimated $190K.
  • Family Legacy Inc fully exited Novartis in Q4 2024, selling an estimated $374K.
  • Family Legacy Inc's ten largest holdings make up 24% of its $295M portfolio in Q4 2024.
  • Family Legacy Inc opened 3 new positions and closed 4 in Q4 2024.
  • Family Legacy Inc's portfolio value fell 1.9% quarter-over-quarter to $295M.

Based on Family Legacy Inc's 13F filing for Q4 2024, filed 12 Feb 2025.